These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
918 related articles for article (PubMed ID: 17034535)
1. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Hengge UR; Krause W; Hofmann H; Stadler R; Gross G; Meurer M; Brinkmeier T; Frosch P; Moll I; Fritsch P; Müller K; Meykadeh N; Marini A; Ruzicka T; Gollnick H Br J Dermatol; 2006 Nov; 155(5):1021-8. PubMed ID: 17034535 [TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvement. Kim GW; Park HJ; Kim HS; Kim SH; Ko HC; Kim BS; Kim MB J Dermatol; 2012 Feb; 39(2):145-50. PubMed ID: 22044240 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Böhm M; Frieling U; Luger TA; Bonsmann G Arch Dermatol; 2003 Jul; 139(7):922-4. PubMed ID: 12873890 [TBL] [Abstract][Full Text] [Related]
4. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases. Goldstein AT; Marinoff SC; Christopher K J Reprod Med; 2004 Oct; 49(10):778-80. PubMed ID: 15568399 [TBL] [Abstract][Full Text] [Related]
5. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. Boms S; Gambichler T; Freitag M; Altmeyer P; Kreuter A BMC Dermatol; 2004 Oct; 4(1):14. PubMed ID: 15485581 [TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Ebert AK; Rösch WH; Vogt T Eur Urol; 2008 Oct; 54(4):932-7. PubMed ID: 18374471 [TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl. Goldstein AT; Marinoff SC; Christopher K J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):35-7. PubMed ID: 15010037 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment. Matsumoto Y; Yamamoto T; Isobe T; Kusunoki T; Tsuboi R J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148 [TBL] [Abstract][Full Text] [Related]
10. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. Assmann T; Becker-Wegerich P; Grewe M; Megahed M; Ruzicka T J Am Acad Dermatol; 2003 Jun; 48(6):935-7. PubMed ID: 12789187 [TBL] [Abstract][Full Text] [Related]
11. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A; Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898 [TBL] [Abstract][Full Text] [Related]
12. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL; Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204 [TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K; Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017 [TBL] [Abstract][Full Text] [Related]
14. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R; Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341 [TBL] [Abstract][Full Text] [Related]
15. Does treatment of vulvar lichen sclerosus influence its prognosis? Cooper SM; Gao XH; Powell JJ; Wojnarowska F Arch Dermatol; 2004 Jun; 140(6):702-6. PubMed ID: 15210461 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis. Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874 [TBL] [Abstract][Full Text] [Related]
17. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C; Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%. Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A Drugs Exp Clin Res; 2005; 31(4):141-5. PubMed ID: 16223203 [TBL] [Abstract][Full Text] [Related]
19. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series. Lonsdale-Eccles AA; Velangi S Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755 [TBL] [Abstract][Full Text] [Related]
20. Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo controlled study. Ioannides D; Lazaridou E; Apalla Z; Sotiriou E; Gregoriou S; Rigopoulos D J Urol; 2010 Apr; 183(4):1395-9. PubMed ID: 20171665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]